Cadus Pharmaceutical Corp. (KDUS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS)

KDUS 1.600

0.0%

Jul 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tomato who wrote (1128)	9/3/2003 11:01:44 AM
From: scaram(o)uche	of 1833

SEQUENOM Increases Throughput and Capacity for MassARRAY System Wednesday September 3, 10:52 am ET New Application Note For Increased Multiplexing Now Available SAN DIEGO, Sept. 3 /PRNewswire-FirstCall/ -- SEQUENOM, Inc. (Nasdaq: SQNM - News) today announced a new method for increased multiplexing using the Company's MassARRAY(TM) system. This new method enables customers to analyze up to 15 single nucleotide polymorphisms (SNPs) in an individual reaction using existing MassARRAY hardware and software components. Furthermore, SEQUENOM's assay design software supports the automated design of multiplexed SNP assays without the need for costly and time-consuming optimization or validation. (snip)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next